Advances in Clinical Chemistry

Publishes cutting-edge reviews in the field of clinical chemistry that include the expertise of international contributors

Gregory S. Makowski (Edited by)

9780323988513, Elsevier Science

Hardback, published 3 August 2022

234 pages
22.9 x 15.2 x 2.1 cm, 0.48 kg

Advances in Clinical Chemistry, Volume 109, the latest installment in this internationally acclaimed series, contains chapters authored by world-renowned clinical laboratory scientists, physicians and research scientists. The serial discusses the latest and most up-to-date technologies related to the field of clinical chemistry, with this new release focusing on Biomarkers of dysfunctional visceral fat, Immunoassay Design and Biotin Interference, Orexin/Hypocretin and Major Psychiatric Disorders and more.

1. Biomarkers of dysfunctional visceral fat
Alejandro Gugliucci
2. Biomarkers in Cardiogenic Shock
Johan Lassus
3. Cysteine and related aminothiols in cardiovascular disease, obesity and insulin resistance
Maria Leonor Pavao
4. Oligoclonal bands: an immunological and clinical approach
Carmen Cabrera
5. Immunoassay Design and Biotin Interference
Amitava Dasgupta
6. Orexin/Hypocretin and Major Psychiatric Disorders
Tiao-Lai Huang

Subject Areas: Biochemistry [PSB]